Poster is available to registered attendees only via the On Demand ASCO website, as per congress regulations. 

Poster Session:  Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Presentation Date and Time: Monday, 3 June, 2024; 9:00 - 12:00 CDT

Link to Published Abstract
 

Publication
  • ASCO •
  • 3 June, 2024 •
  • •

Efficacy of pacritinib in patients with myelofibrosis who have both thrombocytopenia and anemia

Pankit Vachhani, Vikas Gupta , Francesca Palandri, Purvi Suthar, Sarah Buckley, Karisse Roman-Torres, Prithviraj Bose

Publication
  • ASCO •
  • 3 June, 2024 •
  • •

Impact of pacritinib on symptoms in with thrombocytopenia and myelofibrosis who require red blood cell transfusion

Stephen Oh, James K. McCloskey, Marta Sobas, Sarah Buckley, Purvi Suthar, Karisse Roman-Torres, Aaron Thomas Gerds

Publication
  • ASCO •
  • 3 June, 2024 •
  • •

LOTIS-5: An ongoing, phase 3, randomized study of loncastuximab tesirine with rituximab (Lonca-R) versus immunochemotherapy in patients with R/R DLBCL

Michal Kwiatek , Carmelo Carlo-Stella , Andrzej Urban, Andrew Niewiarowski, Luqiang Wang, Mehdi Hamadani

Publication
  • SOHO •
  • 4 September, 2025 •
  • •

Cytopenia is associated with real-world disease progression and diminished survival in patients with myelofibrosis: Analysis of a US national administrative claims database

Lindsay AM Rein, Nicole M Engel-Nitz, Michael Marrone, Jeffrey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Aaron T Gerds, Lucia Masarova

Available materials

Poster
Publication
  • SOHO •
  • 4 September, 2025 •
  • •

Hematologic response in patients with myelofibrosis treated with pacritinib in real-word clinical settings

Raajit Rampal, Samantha Eiffert, Michael Marrone, Lisa Morere, Abiola Oladapo, Purvi Suthar, Anupama Vasudevan, Michael Vredenburg , John Mascarehnas

Available materials

Poster
Publication
  • SOHO •
  • 3 September, 2025 •
  • •

Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib previously treated with ruxolitinib

John Mascarehnas, Samantha Eiffert, Michael Marrone, Lisa Morere, Abiola Oladapo, Anubhav Sharma, Purvi Suthar, Anupama Vasudevan, Michael Vredenburg , Raajit Rampal

Available materials

Poster
Publication
  • EHA •
  • 15 June, 2025 •
  • •

Real-World Treatment Patterns and Clinical Outcomes in Patients with Myelofibrosis Treated with Pacritinib (PAC) with platelets ≥50 x10^9/L at PAC initiation: Interim results from the MY-PAC Study

Doug Tremblay, Abiola Oladapo, Emily Levine, Michael Marrone, Djibril Liassou, Purvi Suthar, Adina Geprifti, Gerard Hoehn, Michael Vredenburg , Bruce Feinberg, Naveen Pemmaraju, James Rossetti

Available materials

Poster
Sign up for alerts